Qinghai belt quantity procurement results announced

Medicine Network July 27th, July 23rd, Qinghai Province public medical institutions drug belt procurement to be selected resultsAccording to the document requirements of the Joint Meeting Office of the Department of Centralized Procurement and Use of Drugs in Qinghai Province, "The Work Programme for the Central Procurement of Drugs and Medical Supplies in Qinghai Province 2020" (Joint Office for The Acquisition of Medicines (2020) No4), 59 drugs will be purchased in a volume, and the results of the proposed election will now be published, with the public ity being from July 23 to July 29, 2020After combing the relevant varieties of Qinghai Province, it was found that a total of 59 drugs were involved in the procurement of Qinghai Province, of which 37 were injections, including Chinese medicine injections, biologics, as well as eye drops and inhalersUp to now, there are Shandong, Shanxi, Hunan, Hebei, Jiangxi and other provinces and cities to carry out the volume of procurement, Qinghai Province is the first batch of biological products, traditional Chinese medicine and Chinese medicine injections into the collection of areas, such as sputum hydrothermal injection, thrombosis, blood plug-in tong and other well-known Chinese medicine are included in the list, which also caused widespread concern in the industryIt is understood that qinghai Province will be the province at all levels of public medical institutions reported 70% of the total procurement volume for the agreed procurement volume (antibiotics at all levels of public medical institutions in the province reported 50% of the total procurement amount as agreed procurement volume)Qinghai Provincial documents show that it in accordance with the principle of step-by-step promotion, to carry out drugs, medical supplies centralized procurement work: 1, with volume procurementThe generic name drugs corresponding to the basic drugs and medical insurance drugs corresponding to the large clinical dosage, the high purchase amount and the sufficient competitionNational and inter-provincial alliance organizations focus on the volume of procurement of selected drugs and medical supplies, in accordance with the relevant policies2, hanging network procurementEmergency rescue drugs, shortage drugs, national medical insurance negotiationdrugs, inter-provincial alliance negotiations on drugs, the state does not centralize the amount of procurement through the quality of efficacy consistency evaluation of generic drugs, test reagents, provincial unloaded procurement of drugs, medical supplies; 3, the price limit network procurementWith volume procurement of the same varieties of unselected drugs, medical supplies and non-medical insurance drugs, medical supplies4, the volume of joint band procurementForeign provinces have carried out the volume of procurement of selected drugs, medical supplies, combined with the actual situation in Qinghai Province, summary of the annual procurement volume, linked to the foreign provinces in the selection of price band procurementAmong them, the third article is particularly important, with the volume of procurement of the same varieties of unselected drugs, medical supplies prices according to not higher than the price of the winning network procurement; According to the results of the proposed election announced by Qinghai Province, a total of 61 products presented the proposed winning (without the amount of price limit hanging network), which is not a good news for the non-original research drugs not selected - even if the price is insisted on and abandoned the winning bid, if you want to obtain the remaining 30% of the market, you want to reduce the price to the same price as the winning price to have a chance to hang up the net; From the collection rules, if not in place to reduce prices, products will not only lose 70% of the volume of procurement market, but also lose access to the remaining market, then Qinghai Province's price reduction, is very fierceTraditional Chinese medicine, biological products into the collection of Qinghai Province on Chinese traditional medicine and biological products collection, has a certain demonstration and advance significance, the final result sesame may also be the National Health Insurance Bureau to learn and adoptOn July 15-16, the relevant departments of the State Medical Security Administration held a symposium to listen to expert opinions and suggestions on the centralized procurement of biological products (including insulin) and traditional Chinese medicines, to study and improve procurement policies in related fields, and to promote the reform of procurement methods There has been news in the industry, this time the experts in the future biological products and traditional Chinese medicine on the collection of related issues there is a certain controversy, especially on the basis of the evaluation of quality consistency, how to carry out the classification of quality level On the one hand, Chinese traditional medicine because of different processes, different raw materials, relatively more difficult to measure quality; At present, the sales ranking of the previous Chinese medicine varieties are more exclusive or quasi-exclusive varieties, injection varieties, and the symposium made it clear that the exclusive varieties of traditional Chinese medicine is not considered In addition, some varieties of biological products have been equipped with the conditions for collection, such as belavbead monotonica and Adamu monoto-resistance has formed a "one original research and two biological similar drugs" three patterns, has met the standards of collection Heavy varieties such as insulin glargine have also initially formed the collection conditions, but compared with the relatively small number of chemical generics manufacturers, it is not expected to form a large internal volume situation Southwest Securities has analyzed that: China's overall production capacity of biological products is low, in the short term is difficult to expand quickly, many enterprises are difficult to ensure the stability of supply, but also to carry out the purchase of a certain degree of difficulty At the beginning of 2020, Wuhan piloted insulin in the country, the expected decline is relatively small, this is the first time insulin was included in the regional collection, according to the insulin action and ratio of different grouping Qinghai Province's band procurement announced results, its biological products price reduction performance, bidding rules and winning results may bring demonstration significance to the future national collection